Photo coming soon
Tirzepatide
Shipping and payment
Chemistry & specifications
Reference data from public databases. For research use only.
| CAS Number | 2023788-19-2 |
|---|---|
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813 g/mol |
| Residue Count | 39 |
| Sequence (1-letter) | YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS |
| PubChem CID | 156588324 → |
Common questions
What pack sizes and strengths are available for Tirzepatide?
Tirzepatide is offered as a 3-vial kit, a single vial, or a 10-vial box. Available strengths: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg per vial. Every vial in a kit or box is the strength you select. The price per vial for each pack is shown under the price.
How quickly does Tirzepatide ship?
Tirzepatide in 5 mg, 10 mg, and 20 mg ships the same day when you order Monday to Friday before 3:00 PM Pacific. Orders after the cutoff, on weekends, or on US federal holidays ship the next business day, and never later than 2 business days after the order. The 15 mg, 30 mg, 40 mg, 50 mg, and 60 mg strengths are prepared to order and dispatched within 7 business days. Carrier transit then takes up to 3 business days within the contiguous United States. Standard shipping is a $18.99 flat rate and free on orders over $200.
How should Tirzepatide be stored?
Lyophilized (freeze-dried) vials tolerate normal shipping at room temperature. On arrival, keep them sealed, dry and away from light: a refrigerator at about 4 °C for the short term, or −20 °C or colder for long-term storage. Let a cold vial reach room temperature before opening it so moisture does not condense on the powder.
How do I work out the concentration after reconstitution?
Concentration in mg/mL equals the vial amount in mg divided by the mL of solvent added. Our free reconstitution calculator also shows the mg held at each 0.1 mL mark.
Is Tirzepatide for human use?
No. Tirzepatide is sold strictly for laboratory research use. It is not a drug, food, dietary supplement, or cosmetic, has not been evaluated by the FDA, and is not for human or veterinary use. Purchasers must be 21 or older.
Research background
Chemistry, identity, and a summary of the peer-reviewed literature on Tirzepatide.
Read the Tirzepatide research background → Reconstitution calculator →Peer-reviewed research
Every research claim on this page traces to one of the 5 publications below.
- Tirzepatide for Obesity Treatment and Diabetes PreventionN Engl J Med (2025)View publication →
- Tirzepatide as Compared with Semaglutide for the Treatment of ObesityN Engl J Med (2025)View publication →
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trialLancet (2023)View publication →
- Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 DiabetesDiabetes Care (2023)View publication →
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysisDiabetologia (2022)View publication →



